Loading market dashboard
NovoCure Limited
NVCRHealthcareNASDAQUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
NovoCure Limited · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $1.75B | $1.68B - $1.84B | -$318.63M | $4.31 | 3 |
| Dec 2029 | $1.47B | $1.41B - $1.54B | -$266.94M | $2.07 | 3 |
| Dec 2028 | $933.89M | $927.10M - $940.68M | -$169.80M | -$0.607 | 4 |
| Dec 2027 | $777.26M | $708.11M - $847.62M | -$141.32M | -$1.171 | 6 |
| Dec 2026 | $703.91M | $690.13M - $712.87M | -$127.98M | -$1.594 | 6 |
| Dec 2025 | $655.40M | $650.97M - $656.88M | -$119.16M | -$1.401 | 5 |
| Dec 2024 | $605.20M | $605.15M - $605.25M | -$110.04M | -$1.296 | 3 |
| Dec 2023 | $549.96M | $527.65M - $576.32M | -$99.99M | -$1.575 | 2 |
| Dec 2022 | $537.80M | $517.72M - $566.30M | -$42.73M | -$0.824 | 2 |
| Dec 2021 | $535.00M | $515.03M - $563.35M | -$106.82M | -$0.416 | 3 |
| Dec 2020 | $494.40M | $475.94M - $520.60M | -$62.96M | $0.262 | 3 |
| Dec 2019 | $351.30M | $338.18M - $369.92M | $4.41M | -$0.113 | 2 |